Novavax to Present at the Wedbush Securities Life Sciences Management Access
GAITHERSBURG, Md., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the
discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, announced today that Barclay "Buck" Phillips, SVP,
Chief Financial Officer and Treasurer, will present at the Wedbush Securities
Life Sciences Management Access Conference to be held on Wednesday, August 13,
2014 at 3:40 pm ET in New York City at the Le Parker Meridien hotel.
A live webcast link for the presentation will be available via the company's
website at www.novavax.com under Investor Info/Events.
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating vaccines and vaccine adjuvants to address a broad range of infectious
diseases worldwide. Using innovative proprietary recombinant nanoparticle
vaccine technology, the company produces vaccine candidates to efficiently and
effectively respond to both known and newly emergent diseases.
CONTACT: Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Press spacebar to pause and continue. Press esc to stop.